Bentham Science Logo

Current Radiopharmaceuticals

Volume 12, 3 Issues, 2019
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access

Aims & Scope

Current Radiopharmaceuticals publishes original research articles, letters, full-length/mini reviews, drug clinical trial studies and guest edited issues on all aspects of research and development of radiolabelled compound preparations, covering studies related to nuclear medicine, molecular imaging, radionuclide therapy, as radiology, oncology and radiotherapy and basic research. The scope of the journal also covers the following areas: radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research and applications.

Current Radiopharmaceuticals

,

Volume 12

-

Number 3



Review Article



Review Article   Open Access

Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing Countries

, 12(3): 187 - 200

Efrain Araujo Perini *, Mikhail Skopchenko, Tran Thu Hong , Rahmat Harianto , Alexis Maître, Maidelys Rosa Rodríguez Rodríguez , Nathalia de Oliveira Santos , Yinglei Guo, Xiangyu Qin , Carlos A. Zeituni and Valeriia N. Starovoitova


DOI: 10.2174/1874471012666190328164253


Review Article



Review Article   Open Access



Research Article

Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience

, 12(3): 220 - 228

Laura Evangelista*, Lea Cuppari, Luisa Bellu, Daniele Bertin, Mario Caccese , Pasquale Reccia, Vittorina Zagonel and Giuseppe Lombardi


DOI: 10.2174/1874471012666190115124536


Research Article



Research Article   Open Access

68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers

, 12(3): 238 - 246

Ferdinando Calabria*, Robert Pichler, Mario Leporace, Johannes Wolfsgruber, Pierluigi Coscarelli, Andreas Dunzinger, Orazio Schillaci, Giuseppe Lucio Cascini and Antonio Bagnato


DOI: 10.2174/1874471012666190515090755


Research Article

Evaluation of the Radioprotective Effects of Melatonin Against Ionizing Radiation-Induced Muscle Tissue Injury

, 12(3): 247 - 255

Dheyauldeen Shabeeb, Mansoor Keshavarz , Alireza Shirazi*, Gholamreza Hassanzadeh*, Mohammed Reza Hadian, Azin Nowrouzi, Masoud Najafi* and Ahmed Eleojo Musa


DOI: 10.2174/1874471012666190219120329


Articles Ahead of Print

Malignant Cutaneous Melanoma: Updates in PET Imaging


Riccardo Laudicella*, Lucia Baratto*, Fabio Minutoli, Sergio Baldari and Andrei Iagaru


DOI: 10.2174/1874471012666191015095550
View Abstract





Clinical Value of PET/CT in Staging Melanoma and Potential New Radiotracers


Annunziata S*, Laudicella R, Caobelli F, Pizzuto DA and Young AIMN Working Group


DOI: 10.2174/1874471012666191015094620
View Abstract


A Preliminary Study for Quantitative Assessment with HFUS (High- Frequency Ultrasound) of Nodular Skin Melanoma Breslow Thickness in Adults Before Surgery: Interdisciplinary Team Experience


Alfonso Reginelli*, Maria Paola Belfiore, Anna Russo, Fabrizio Turriziani, Elvira Moscarella, Teresa Troiani, Gabriella Brancaccio, Andrea Ronchi, Emilio Giunta, Antonello Sica, Francesco Iovino, Fortunato Ciardiello, Renato Franco, Giuseppe Argenziano, Roberto Grassi and Salvatore Cappabianca


DOI: 10.2174/1874471012666191007121626
View Abstract View on PubMed


Clinical and Prognostic Value of 18F-FDG-PET/CT in the Restaging Process of Recurrent Cutaneous Melanoma


Domenico Albano, Demetrio Familiari, Maria Concetta Fornito, Salvatore Scalisi, Riccardo Laudicella, Massimo Galia, Emanuele Grassedonio, Antonella Ruggeri, Gloria Ganduscio, Marco Messina, Massimiliano Spada, Massimo Midiri and Pierpaolo Alongi*


DOI: 10.2174/1874471012666191009161826
View Abstract View on PubMed


Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas


Francesco Bertagna*, Domenico Albano, Elisabetta Cerudelli, Maria Gazzilli, Raffaele Giubbini and Giorgio Treglia


DOI: 10.2174/1874471012666191017093721
View Abstract View on PubMed


Analysis of Unusual Adverse Effects After Radium-223 Dichloride Administration


Viviana Frantellizzi*, Mariano Pontico, Arianna Pani, Roberto Pani and Giuseppe De Vincentis


DOI: 10.2174/1874471012666190927115331
View Abstract View on PubMed



Abstracts Ahead of Print

There are currently no Abstracts Ahead of Print available for this journal.

Editor's Choice


68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers

, 2019; 12(3): 238 - 246

Ferdinando Calabria*, Robert Pichler, Mario Leporace, Johannes Wolfsgruber, Pierluigi Coscarelli, Andreas Dunzinger, Orazio Schillaci, Giuseppe Lucio Cascini and Antonio Bagnato


DOI: 10.2174/1874471012666190515090755




[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations

, 2019; 12(1): 58 - 71

Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*


DOI: 10.2174/1874471012666190102165053





Ga-68 Nanoparticles and Ultra-small Nanoparticle: Next Generation of PET Radiopharmaceuticals?

, 2018; 11(2): 123 - 129

Mohammed Al-Qahtani, Yousif Al Malki, Hadeel Mutwali, Edward Helal-Neto and Ralph Santos-Oliveira*


DOI: 10.2174/1874471011666180418110206



Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy

, 2018; 11(1): 34 - 45

Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa


DOI: 10.2174/1874471011666171229123130




PET/MR Tomographs: A Review with Technical, Radiochemical and Clinical Perspectives

, 2017; 10(3): 184 - 194

Giampiero Giovacchini, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello*


DOI: 10.2174/1874471010666170816125051



Open Access Articles

The Screening of Renoprotective Agents by 99mTc-DMSA: A Review of Preclinical Studies

, 2019; 12(3): 211 - 219

Masoud Rezaei , Maryam Papie, Mohsen Cheki*, Luigi Mansi, Sean Kitson and Amirhossein Ahmadi




Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing Countries

, 2019; 12(3): 187 - 200

Efrain Araujo Perini *, Mikhail Skopchenko, Tran Thu Hong , Rahmat Harianto , Alexis Maître, Maidelys Rosa Rodríguez Rodríguez , Nathalia de Oliveira Santos , Yinglei Guo, Xiangyu Qin , Carlos A. Zeituni and Valeriia N. Starovoitova




[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations

, 2019; 12(1): 58 - 71

Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*




Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level

, 2019; 12(1): 40 - 48

Ingrid Kreimerman, Erick Mora-Ramirez, Laura Reyes, Manuel Bardiès, Eduardo Savio* and Henry Engler




Comparison of 99mTc Injected Activity with Prescribed Activity in Four Types of Nuclear Medicine Exams

, 2019; 12: 1 - 6 (E-Pub Ahead of Print)

Muhammad Isa Khan, Umme Farwa, Tahir Iqbal, Saadat Ali, Aalia Nazir and Mohsin Ijaz*




Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications

, 2019; 12: 1 - 17 (E-Pub Ahead of Print)

Sara Pastorino, Mattia Riondato, Licia Uccelli, Giampiero Giovacchini, Elisabetta Giovannini, Valerio Duce and Andrea Ciarmiello*




Preparation and Biological Evaluation of 67Gallium- Labeled Iranian Hemiscorpius Lepturus Scorpion Venom

, 2019; 12: 1 - 8 (E-Pub Ahead of Print)

Amir Jalali*, Mona Haddad Zahmatkesh, Amir Reza Jalilian, Amir Taheri Borujeni and Behrouz Alirezapour





Analysis of Unusual Adverse Effects After Radium-223 Dichloride Administration

, 2019; 12: 1 - 5 (E-Pub Ahead of Print)

Viviana Frantellizzi*, Mariano Pontico, Arianna Pani, Roberto Pani and Giuseppe De Vincentis




A Preliminary Study for Quantitative Assessment with HFUS (High- Frequency Ultrasound) of Nodular Skin Melanoma Breslow Thickness in Adults Before Surgery: Interdisciplinary Team Experience

, 2019; 12: 1 - 7 (E-Pub Ahead of Print)

Alfonso Reginelli*, Maria Paola Belfiore, Anna Russo, Fabrizio Turriziani, Elvira Moscarella, Teresa Troiani, Gabriella Brancaccio, Andrea Ronchi, Emilio Giunta, Antonello Sica, Francesco Iovino, Fortunato Ciardiello, Renato Franco, Giuseppe Argenziano, Roberto Grassi and Salvatore Cappabianca




Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the Last Decade

, 2019; 12: 1 - 10 (E-Pub Ahead of Print)

Natale Quartuccio*, Massimiliano Siracusa, Marco Pappalardo, Annachiara Arnone and Gaspare Arnone





Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas

, 2019; 12: 1 - 5 (E-Pub Ahead of Print)

Francesco Bertagna*, Domenico Albano, Elisabetta Cerudelli, Maria Gazzilli, Raffaele Giubbini and Giorgio Treglia




An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

, 2018; 11(3): 200 - 208

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer




Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

, 2018; 11(3): 156 - 172

Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*





Most Cited Articles

Review Article

An overview of targeted alpha therapy with <sup>225</sup>Actinium and <sup>213</sup>Bismuth

, 2018; 11(3): 200-208.

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer


DOI: 10.2174/1874471011666180502104524


Review Article

Mechanisms of radiation bystander and non-targeted effects: Implications to radiation carcinogenesis and radiotherapy

, 2018; 11(1): 34-45.

Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa


DOI: 10.2174/1874471011666171229123130


Research Article

Biochemical and histopathological evaluation of the radioprotective effects of melatonin against gamma ray-induced skin damage

, 2019; 12(1): 72-81.

Dheyauldeen Shabeeb, Masoud Najafi, Ahmed Eleojo Musa, Mansoor Keshavarz, Alireza Shirazi*, Gholamreza Hassanzadeh*, Mohammed Reza Hadian and Hedayat Samandari


DOI: 10.2174/1874471012666181120163250


Review Article

Development of <sup>225</sup>ac radiopharmaceuticals: TRIUMF perspectives and experiences

, 2018; 11(3): 156-172.

Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*


DOI: 10.2174/1874471011666180416161908


Review Article

Review: The role of radiolabeled DOTA-conjugated peptides for imaging and treatment of childhood neuroblastoma

, 2018; 11(1): 14-21.

Natasha Alexander, Reza Vali, Hojjat Ahmadzadehfar, Amer Shammas and Sylvain Baruchel*


DOI: 10.2174/1874471011666171215093112


Review Article

PET/CT with <sup>68</sup>Ga-PSMA in prostate cancer: Radiopharmaceutical background and clinical implications

, 2018; 11(1): 4-13.

Giampiero Giovacchini*, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello


DOI: 10.2174/1874471010666171101121803



Review Article

The production of Ac-225

, 2018; 11(3): 173-179.

Jonathan W. Engle*


DOI: 10.2174/1874471011666180418141357


Review Article

Radiopharmaceuticals labelled with copper radionuclides: Clinical results in human beings

, 2018; 11(1): 22-33.

Giulia Anna Follacchio*, Maria Silvia De Feo, Giuseppe De Vincentis, Francesco Monteleone and Mauro Liberatore


DOI: 10.2174/1874471011666171211161851


Perspective

PET/MRI in neuroendocrine tumours: Blessings and curses

, 2019; 12(2): 96-97.

Mapelli Paola, De Cobelli F and Maria Picchio


DOI: 10.2174/1874471012999190404151701


Review Article

State of the art and recent developments of radiopharmaceuticals for pancreatic neuroendocrine tumors imaging

, 2019; 12(2): 107-125.

Angela Carollo*, Stefano Papi, Chiara M. Grana, Luigi Mansi and Marco Chinol


DOI: 10.2174/1874471012666190306104450


Research Article

Evaluating the radioprotective effect of curcumin on rat’s heart tissues

, 2019; 12(1): 23-28.

Sedighe Kolivand, Peyman Amini, Hana Saffar, Saeed Rezapoor, Elahe Motevaseli*, Masoud Najafi*, Farzad Nouruzi, Dheyauldeen Shabeeb and Ahmed Eleojo Musa


DOI: 10.2174/1874471011666180831101459


Research Article

In vivo evaluation of [ <sup>225</sup> Ac]Ac-DOTA <sup>ZOL</sup> for α-therapy of bone metastases

, 2018; 11(3): 223-230.

Nina Pfannkuchen, Nicole Bausbacher, Stefanie Pektor, Matthias Miederer and Frank Rosch*


DOI: 10.2174/1874471011666180604083911


Research Article

Automated synthesis of <sup>68</sup>Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations

, 2018; 11(2): 130-137.

Licia Uccelli*, Alessandra Boschi, Corrado Cittanti, Petra Martini, Luca Lodi, Elisa Zappaterra, Simona Romani, Samanta Zaccaria, Davide Cecconi, Ilaria Rambaldi, Ivan Santi, Stefano Panareo, Melchiore Giganti and Mirco Bartolomei


DOI: 10.2174/1874471011666180509101420


Research Article

Feasibility and evaluation of automated methods for radiolabeling of radiopharmaceutical kits with gallium-68

, 2019; 12(3): 229-237.

Alban Revy, François Hallouard*, Sandrine Joyeux-Klamber, Andrea Skanjeti, Catherine Rioufol and Marc Fraysse


DOI: 10.2174/1874471012666190110170623



Most Accessed Articles







68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers

, 2019; 12(3): 238-246.

Ferdinando Calabria*, Robert Pichler, Mario Leporace, Johannes Wolfsgruber, Pierluigi Coscarelli, Andreas Dunzinger, Orazio Schillaci, Giuseppe Lucio Cascini and Antonio Bagnato


DOI: 10.2174/1874471012666190515090755


Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing Countries

, 2019; 12(3): 187-200.

Efrain Araujo Perini *, Mikhail Skopchenko, Tran Thu Hong , Rahmat Harianto , Alexis Maître, Maidelys Rosa Rodríguez Rodríguez , Nathalia de Oliveira Santos , Yinglei Guo, Xiangyu Qin , Carlos A. Zeituni and Valeriia N. Starovoitova


DOI: 10.2174/1874471012666190328164253


An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

, 2018; 11(3): 200-208.

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer


DOI: 10.2174/1874471011666180502104524





Editor-in-Chief

Sean L. Kitson
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
Northern Ireland

Biography View Full Editorial Board

Journal History

Current Radiopharmaceuticals Journal was launched in 2008. Dr. Sean L. Kitson serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.42

Related Journals

Related eBooks

eBooks Catalog